{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:43:04Z","timestamp":1790790184893,"version":"4.1.0"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,7,25]]},"DOI":"10.1253\/circj.cj-23-0223","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T22:11:40Z","timestamp":1686607900000},"page":"1047-1055","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition"],"prefix":"10.1253","volume":"87","author":[{"given":"Seiji","family":"Takashio","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Kato","sequence":"additional","affiliation":[{"name":"Kato Orthopedics Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Tashima","sequence":"additional","affiliation":[{"name":"Kumamoto Orthopaedic Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Critical Care, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Oguni","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kuyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Izumiya Y, Takashio S, Oda S, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. <i>J Cardiol<\/i> 2018; 71: 135\u2013143.","DOI":"10.1016\/j.jjcc.2017.10.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. <i>Circulation<\/i> 2017; 135: 1357\u20131377.","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2015; 36: 2585\u20132594.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, et al. Redefining the epidemiology of cardiac amyloidosis: A systematic review and meta-analysis of screening studies. <i>Eur J Heart Fail<\/i> 2022; 24: 2342\u20132351.","DOI":"10.1002\/ejhf.2532"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. <i>Circulation<\/i> 2016; 133: 2404\u20132412.","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. <i>N Engl J Med<\/i> 2021; 385: 46\u201358.","DOI":"10.1056\/NEJMoa2028631"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maurer MS, Schwartz JH, Gundapaneni B, Elliott P, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Solomon SD, Adams D, Kristen A, Grogan M, Gonz\u00e1lez-Duarte A, Maurer MS, et al. Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis. <i>Circulation<\/i> 2019; 139: 431\u2013443.","DOI":"10.1161\/CIRCULATIONAHA.118.035831"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 Guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac amyloidosis: Evolving diagnosis and management: A Scientific Statement from the American Heart Association. <i>Circulation<\/i> 2020; 142: e7\u2013e22.","DOI":"10.1161\/CIR.0000000000000792"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2021; 42: 1554\u20131568.","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamada T, Takashio S, Arima, Y, Nishi M, Morioka M, Hirakawa K, et al. Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan. <i>ESC Heart Fail<\/i> 2020; 7: 2829\u20132837.","DOI":"10.1002\/ehf2.12884"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fosb\u00f8l EL, R\u00f8rth R, Leicht BP, Schou M, Maurer MS, Kristensen SL, et al. Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. <i>J Am Coll Cardiol<\/i> 2019; 74: 15\u201323.","DOI":"10.1016\/j.jacc.2019.04.054"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. <i>Hum Pathol<\/i> 2011; 42: 1259\u20131264.","DOI":"10.1016\/j.humpath.2010.11.017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. <i>J Am Coll Cardiol<\/i> 2018; 72: 2040\u20132050.","DOI":"10.1016\/j.jacc.2018.07.092"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Donnelly JP, Hanna M, Sperry BW, Seitz WH Jr. Carpal tunnel syndrome: A potential early, red-flag sign of amyloidosis. <i>J Hand Surg Am<\/i> 2019; 44: 868\u2013876.","DOI":"10.1016\/j.jhsa.2019.06.016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Vianello PF, La Malfa G, Tini G, Mazzola V, Miceli A, Santolini E, et al. Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study. <i>Int J Cardiol<\/i> 2021; 329: 144\u2013147.","DOI":"10.1016\/j.ijcard.2020.12.044"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zegri-Reiriz I, de Haro-Del Moral FJ, Dominguez F, Salas C, de la Cuadra P, Plaza A, et al. Prevalence of cardiac amyloidosis in patients with carpal tunnel syndrome. <i>J Cardiovasc Transl Res<\/i> 2019; 12: 507\u2013513.","DOI":"10.1007\/s12265-019-09895-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sugiura K, Kozuki H, Ueba H, Kubo T, Ochi Y, Baba Y, et al. Tenosynovial and cardiac transthyretin amyloidosis in Japanese patients undergoing carpal tunnel release. <i>Circ Rep<\/i> 2021; 3: 338\u2013344.","DOI":"10.1253\/circrep.CR-21-0046"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Westin O, Fosb\u00f8l EL, Maurer MS, Leicht BP, Hasbak P, Mylin AK, et al. Screening for cardiac amyloidosis 5 to 15 years after surgery for bilateral carpal tunnel syndrome. <i>J Am Coll Cardiol<\/i> 2022; 80: 967\u2013977.","DOI":"10.1016\/j.jacc.2022.06.026"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Usuku H, Takashio S, Yamamoto E, Kinoshita Y, Nishi M, Oike F, et al. Usefulness of relative apical longitudinal strain index to predict positive 99 m Tc-labeled pyrophosphate scintigraphy findings in advanced-age patients with suspected transthyretin amyloid cardiomyopathy. <i>Echocardiography<\/i> 2020; 37: 1774\u20131783.","DOI":"10.1111\/echo.14892"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. <i>JACC Heart Fail<\/i> 2019; 7: 709\u2013716.","DOI":"10.1016\/j.jchf.2019.04.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis. Part 1 of 2: Evidence base and standardized methods of imaging. <i>Circ Cardiovasc Imaging<\/i> 2021; 14: e000029.","DOI":"10.1161\/HCI.0000000000000029"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. <i>J Am Coll Cardiol<\/i> 2016; 68: 1014\u20131020.","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, et al. Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. <i>Eur Heart J<\/i> 2022; 43: 2622\u20132632.","DOI":"10.1093\/eurheartj\/ehac259"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: A common cause of carpal tunnel syndrome in the elderly. <i>Hum Pathol<\/i> 2011; 42: 1785\u20131791.","DOI":"10.1016\/j.humpath.2011.03.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hahn K, Urban P, Meli\u00df RR, Axmann HD, Siebert F, R\u00f6cken C. Carpal tunnel syndrome and ATTR-amyloidosis. <i>Handchir Mikrochir Plast Chir<\/i> 2018; 50: 329\u2013334.","DOI":"10.1055\/a-0747-6096"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Ros\u00e9n I. Prevalence of carpal tunnel syndrome in a general population. <i>JAMA<\/i> 1999; 282: 153\u2013158.","DOI":"10.1001\/jama.282.2.153"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gilstrap LG, Dominici F, Wang Y, El-Sady MS, Singh A, Di Carli MF, et al. Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States. <i>Circ Heart Fail<\/i> 2019; 12: e005407.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Khayambashi S, Elzinga K, Hahn C, Chhibber S, Mahe E, Miller R, et al. Amyloidosis tissue confirmation for tafamidis eligibility using transverse carpal ligament and tenosynovium biopsy. <i>Can J Cardiol<\/i> 2022; 38: 1643\u20131646.","DOI":"10.1016\/j.cjca.2022.06.012"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, et al. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis. <i>ESC Heart Fail<\/i> 2018; 5: 27\u201335.","DOI":"10.1002\/ehf2.12203"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/8\/87_CJ-23-0223\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T03:19:08Z","timestamp":1690600748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/87\/8\/87_CJ-23-0223\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-23-0223","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"article-number":"CJ-23-0223"}}